Related Experiment Video
Updated: Jul 18, 2025

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response
Published on: October 3, 2019
Erythema Nodosum Induced by the Pfizer- BioNTech Vaccine
Dessyslava G Nikolaeva1, Ivan A Bogdanov2, Miroslava I Kadurina3
1Dermatology and Venerology Clinic, Acibadem City Clinic Tokuda Hospital, Sofia, Bulgaria; desi_nina@abv.bg.
Abstract:
A 42-year-old man presented with a painful nodular dermatitis with 38.5°C fever and joint pain, which started overnight. The patient had taken the first dose of Pfizer-BioNTech (Comirnaty, INN-COVID-19 mRNA) vaccine 8 days ago. He denied any kind of recent infections, inflammatory conditions, malignancies, or drugs administration.
Related Concept Videos
Cross-reactivity
Endocarditis II: Clinical Features of Infective Endocarditis
Allergic Drug Reactions
Myocarditis I: Introduction
Allergic Reactions
Myocarditis III: Medical Management

